IL2 and viral infectious disease: Selective Treg expansion can also be achieved using anti-IL-2 monoclonal antibodies (e.g., IL-2/JES6-1 complexes), which increase Treg/Teff ratios and alleviating inflammation, offering a precise means to correct immune dysregulation in viral infections [111].